نتائج البحث

المساهمون: Bonnal, R. J. P., Rossetti, G., Lugli, E., De Simone, M., Gruarin, P., Brummelman, J., Drufuca, L., Passaro, M., Bason, R., Gervasoni, F., Della Chiara, G., D'Oria, C., Martinovic, M., Curti, S., Ranzani, V., Cordiglieri, C., Alvisi, G., Mazza, E. M. C., Oliveto, S., Silvestri, Y., Carelli, E., Mazzara, S., Bosotti, R., Sarnicola, M. L., Godano, C., Bevilacqua, V., Lorenzo, M., Siena, S., Bonoldi, E., Sartore-Bianchi, A., Amatu, A., Veronesi, G., Novellis, P., Alloisio, M., Giani, A., Zucchini, N., Opocher, E., Ceretti, A. P., Mariani, N., Biffo, S., Prati, D., Bardelli, A., Geginat, J., Lanzavecchia, A., Abrignani, S., Pagani, M.

المصدر: Nature Immunology, 22, 735-745
Nature Immunology, 22, 6, pp. 735-745

مصطلحات موضوعية: Male, 0301 basic medicine, Lung Neoplasms, T-Lymphocytes, Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2], medicine.medical_treatment, Programmed Cell Death 1 Receptor, Drug Resistance, Datasets as Topic, Kaplan-Meier Estimate, Granzymes, 0302 clinical medicine, Cancer immunotherapy, Single-cell analysis, 80 and over, Immunology and Allergy, RNA-Seq, Non-Small-Cell Lung, Immune Checkpoint Inhibitors, Adjuvant, Colectomy, Chitinases, Cell Differentiation, Forkhead Transcription Factors, Middle Aged, Flow Cytometry, Regulatory, Adult, Aged, Aged, 80 and over, Carcinoma, Non-Small-Cell Lung, Cell Proliferation, Chemotherapy, Adjuvant, Clonal Hematopoiesis, Colon, Colorectal Neoplasms, Disease Progression, Drug Resistance, Neoplasm, Female, Gene Expression Regulation, Neoplastic, Humans, Primary Cell Culture, Single-Cell Analysis, T-Box Domain Proteins, T-Lymphocytes, Regulatory, Immunology, Biology, 03 medical and health sciences, Immune system, medicine, Chemotherapy, Neoplastic, Carcinoma, Immunotherapy, 030104 developmental biology, Gene Expression Regulation, Cell culture, Cancer research, Neoplasm, Granzyme K, Eomesodermin Homolog, Checkpoint Blockade Immunotherapy, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73e12ccb9271b3892eb83d8342962f9dTest
https://doi.org/10.1038/s41590-021-00930-4Test

6

ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies

المؤلفون: Eizaburo Sueoka, Naoko Aragane, Akiko Matsumoto, Chiho Nakashima, Shinya Kimura

المصدر: BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Cancer

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Programmed Cell Death 1 Receptor, Adenocarcinoma of Lung, Thoracic malignancy, Pembrolizumab, Gastroenterology, B7-H1 Antigen, 03 medical and health sciences, Immune checkpoint inhibitors, 0302 clinical medicine, Atezolizumab, Internal medicine, Genetics, medicine, Humans, RC254-282, Aged, ALDH2, Aged, 80 and over, business.industry, Research, Aldehyde Dehydrogenase, Mitochondrial, Hazard ratio, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, medicine.disease, Progression-Free Survival, Tumor antigen, rs671, 030104 developmental biology, Oncology, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Adenocarcinoma, Female, Nivolumab, PD-L1 inhibitor, business, Progressive disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ee1aa31a4d623a9f302f2f31578d19eTest
https://doaj.org/article/783b884fb5c549228ac601a6b0661e47Test

7

Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach

المؤلفون: Miriam Caramanti, Mariangela Torniai, Francesca Morgese, Francesca Bianchi, Azzurra Onofri, Armando Sabbatini, Gaia Goteri, Rossana Berardi, Silvia Rinaldi, Giulia Marcantognini, Majed Refai, Paola Mazzanti, Cecilia Pompili, Stefano Cascinu, Silvia Pagliaretta, Alessandro Brunelli, Vittorio Paolucci, Giulia Ricci

المساهمون: Berardi, R., Goteri, G., Brunelli, A., Pagliaretta, S., Paolucci, V., Caramanti, M., Rinaldi, S., Refai, M., Pompili, C., Morgese, F., Torniai, M., Marcantognini, G., Ricci, G., Mazzanti, P., Onofri, A., Bianchi, F., Sabbatini, A., Cascinu, S.

المصدر: Expert Opinion on Therapeutic Targets. 24:937-943

مصطلحات موضوعية: Adult, Male, PD-L1, 0301 basic medicine, Thymoma, Programmed Cell Death 1 Receptor, Clinical Biochemistry, B7-H1 Antigen, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Programmed cell death 1, Myasthenia Gravis, PD-1, Drug Discovery, medicine, Humans, Neoplasms, Glandular and Epithelial, RNA, Messenger, immune checkpoint, Thymic carcinoma, Aged, Aged, 80 and over, Pharmacology, biology, Age Factors, Thymus Neoplasms, Middle Aged, thymoma, Prognosis, medicine.disease, Ligand (biochemistry), Immunohistochemistry, Immune checkpoint, Gene Expression Regulation, Neoplastic, 030104 developmental biology, 030220 oncology & carcinogenesis, Disease Progression, biology.protein, Cancer research, Molecular Medicine, Female, thymic carcinoma, Programmed death